Home › Funds › LINDEN ADVISORS LP › IPCX

LINDEN ADVISORS LP position in IPCX

ROIVANT SCIENCES LTD

LINDEN ADVISORS LP reported holding 1,865,000 shares of IPCX (ROIVANT SCIENCES LTD) in its Q2 2026 13F filing — a position valued at US$19.2M, representing 0.83% of its reported portfolio and ranking #6 among its reported holdings. LINDEN ADVISORS LP has disclosed IPCX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)1.86M sh
Reported value held$19.25M
Portfolio Weight0.83%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How LINDEN ADVISORS LP's IPCX position evolved

LINDEN ADVISORS LP first disclosed a stake in IPCX in Q2 2025 at 1,590,000 shares (US$16.3M). The position peaked in Q2 2026 at 1,865,000 shares, worth US$19.2M. Across 5 filings, LINDEN ADVISORS LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,865,000 shares valued at US$19.2M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 1.59M $16.30M New
Q3 2025 1.86M $18.82M Add
Q4 2025 1.86M $18.91M Hold
Q1 2026 1.86M $19.04M Hold
Q2 2026 1.86M $19.25M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IPCX and 13F data

IPCX (ROIVANT SCIENCES LTD) is a company whose sector is not yet classified in our data. 60 other funds we track also report a position in IPCX — the largest reported positions include BERKLEY W R CORP (US$22.8M), RLH Capital LLC (US$14.7M), MMCAP International Inc. SPC (US$14.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IPCX

All IPCX fund holders →

FAQ

How long has LINDEN ADVISORS LP held IPCX?

LINDEN ADVISORS LP has disclosed IPCX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is LINDEN ADVISORS LP's current position in IPCX?

As of Q2 2026, LINDEN ADVISORS LP holds 1.86M shares of IPCX (ROIVANT SCIENCES LTD), valued at $19.25M, representing 0.83% of its reported portfolio and ranking #6.

Has LINDEN ADVISORS LP been buying or selling IPCX?

In the latest 13F filing (Q2 2026), LINDEN ADVISORS LP held unchanged its position in IPCX. The position peaked in Q2 2026 at 1.86M shares.

Which other funds hold IPCX?

Other major institutional holders of IPCX include BERKLEY W R CORP, RLH Capital LLC, MMCAP International Inc. SPC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.